Vedat Ali Yürekli

Vedat Ali Yürekli

Auto-generated profile, based on publicly available information

Vedat Ali Yürekli

Department of Neurology, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
AÇAslı Arican Çelik
Aslı Arican Çelik
ABAhmet Bindal
Ahmet Bindal
SÇSüleyman Sencer Çelik
Süleyman Sencer Çelik
PKPınar Karabacak
Pınar Karabacak
YGYasemin Görgülü
Yasemin Görgülü
VYVedat Ali Yürekli
Vedat Ali Yürekli
SUMMARY OBJECTIVE: The aim of this study was to evaluate optic nerve sheath diameter using ultrasonography in patients with clinical and radiological suspicion of elevated intracranial pressure in the intensive care unit. Elevated intracranial pressure is a critical condition resulting from various intracranial pathologies and constitutes a major cause of morbidity and mortality. METHODS: Several invasive and noninvasive methods are available for detecting elevated intracranial pressure. Although invasive methods are regarded as the gold standard, they are associated with certain disadvantages. Ultrasonographic measurement of optic nerve sheath diameter, a noninvasive technique, has gained prominence owing to its repeatability, bedside applicability, and cost-effectiveness. From June to December 2023, 50 patients with suspected elevated intracranial pressure based on cranial computed tomography findings and clinical presentation, along with 36 healthy volunteers, were included in the study. RESULTS: Optic nerve sheath diameter was significantly greater in patients (right 6.13±0.50 mm, left 6.13±0.51 mm) compared with controls (right 4.23±0.22 mm, left 4.23±0.21 mm; p<0.001). Moreover, optic nerve sheath diameter was significantly correlated with mortality, as well as with Glasgow Coma Scale, Full Outline of UnResponsiveness, Acute Physiology and Chronic Health Evaluation II, and Sequential Organ Failure Assessment scores. Patients with computed tomography findings such as brain edema and midline shift also exhibited significantly elevated optic nerve sheath diameter values. CONCLUSION: Ultrasonographic measurement of optic nerve sheath diameter represents a reliable adjunctive modality for identifying patients with radiological signs of elevated intracranial pressure and for prognostic assessment in the intensive care unit. Nevertheless, the lack of invasive intracranial pressure monitoring as the gold standard constitutes a major limitation, and validation against direct intracranial pressure measurements is warranted in future studies. This technique may be particularly useful in hemodynamically unstable patients who cannot be safely transferred for computed tomography imaging.

1 May 2021 in SDÜ Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
DADuygu Aydemi̇r
Duygu Aydemi̇r
ÖTÖzge Türk
Özge Türk
BCBurak Ceylan
Burak Ceylan
NYNeslişah YILDIRIM
Neslişah YILDIRIM
EBEkin Öykü Baylam
Ekin Öykü Baylam
NSNihat Sengeze
Nihat Sengeze
Covid-19 pandemisinde yapılan araştırmalarda nörolojik belirti ve bulguların hastaların yaklaşık % 36’sında görüldüğü saptanmıştır. Hastalar Covid-19 enfeksiyonunun klasik ateş, öksürük veya solunum sıkıntısı gibi belirtilerinin yanısıra; koku ve/veya tat alma duyusu kaybı, kas ağrısı, inme, baş ağrısı, bilinç bozukluğu, baş dönmesi, epileptik nöbet gibi farklı nörolojik belirtilerle de hastaneye başvurabilmektedir. Bu nörolojik belirti ve bulguların bilinmesi ve bu konudaki farkındalığın artması gerekmektedir. Bu durum, enfeksiyonun yayılmasını önleme ve tedavi etme konusunda oldukça katkı sağlayacaktır. Bu yazı Covid-19 hastalığının şu ana kadar saptanmış olan nörolojik belirtileri ve komplikasyonlarının literatür eşliğinde derlenmesi amacıyla hazırlanmıştır. Bu enfeksiyonla ilgili araştırmalar arttıkça nörolojik tutulumun sanılandan daha fazla olabileceği öngörülmektedir.

1 December 2025 in SDÜ Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
PYPınar Yaşar
Pınar Yaşar
MDMehmet Duray
Mehmet Duray
SKSüleyman Kutluhan
Süleyman Kutluhan
VYVedat Ali Yürekli
Vedat Ali Yürekli
Objective: This study aims to evaluate the relationship between post-stroke urinary incontinence and the severity of spasticity, balance, and gait performance. Material and Method: This cross-sectional study was conducted with 46 patients with stroke. The Modified Rankin Scale (MRS) was used to determine the functional status of the participants. A 24-hour pad test was performed to assess urinary incontinence, and the Danish Prostate Symptom Score (DANN-PSS) was utilized to evaluate urinary function. Spasticity, as one of the motor symptoms, was assessed using the Modified Ashworth Scale (MAS), while balance and gait were evaluated through the Tinetti Balance and Gait Assessment. Results: The mean age of patients with urinary incontinence was significantly higher than that of those without incontinence (p

8 July 2026 in Turkish Journal of Cerebrovascular Diseases
Verified
Journal Article
Open access
PDF file
BGBurak Gürel
Burak Gürel
VYVedat Ali Yürekli
Vedat Ali Yürekli
NSNihat Sengeze
Nihat Sengeze
MKMustafa Karabacak
Mustafa Karabacak
Background: Mechanical thrombectomy is recommended for patients with middle cerebral artery (MCA) segment 1 (M1) occlusion within 6 hours of symptom onset by American Stroke Association. This study aimed to demonstrate the safety of endovascular treatments in MCA M1 infarcts and compare the safety and effectiveness of direct thrombectomy and intravenous tissue plasminogen activator (iv-tPA) bridging therapy before mechanical thrombectomy. Methods: A retrospective, observational study was conducted on patients with large MCA infarction on brain imaging. Patients who received endovascular treatment were included in the endovascular therapy (EVT) group, while who received only iv-tPA were included in the iv-tPA group. Patients who underwent direct mechanical thrombectomy or bridging therapy were identified. Clinical outcomes at 3 months and symptomatic intracerebral hemorrhage (SIH) rates were compared between the groups. Results: The EVT group showed good clinical outcomes (modified Rankin score [mRS] ≤ 2) at 3 months was significantly higher than the iv-tPA group, while; SIH rates were similar. There was no statistically significant difference in terms of good clinical outcomes between direct mechanical thrombectomy and bridging therapy groups. But, SIH rates were significantly higher in the direct mechanical thrombectomy group. Conclusion: Our study showed that for large MCA infarct, EVT provides better clinical outcomes than iv-tPA alone, and that direct mechanical thrombectomy may be an effective choice for patients who are unsuitable for iv-tPA. Additionally, our findings also contribute to the literature indicating that bridging therapy is a safe option.

15 February 2026 in Turkish Journal Of Neurology
Verified
Journal Article
Open access
PDF file
BGBurak Gürel
Burak Gürel
VYVedat Ali Yürekli
Vedat Ali Yürekli
Objectives: This study aims to evaluate the efficacy, safety, and complications of intravenous thrombolytic therapy (IVTT), identify the prognostic factors in treated patients, and assess outcomes in patients aged over 80 years. Patients and methods: Between June 2014 and March 2020, 155 patients with acute ischemic stroke were enrolled in this retrospective observational study and assigned to the IVTT group (44 males, 37 females; median age: 69 years; IQR, 58–79 years) and the non-IVTT group (30 males, 44 females; median age: 74 years; IQR, 65–82 years). The modified Rankin scale score at the third month for all patients and hemorrhagic transformation rates in the IVTT group were recorded. Outcomes were compared between patients aged over and under 80 years within the IVTT group. Results: Good outcomes at the third month were significantly higher in the IVTT group than in the non-IVTT group (37% vs. 17.6%, p = 0.007), with symptomatic intracerebral hemorrhage occurring in 6.2% of patients within the first 36 h after IVTT; baseline National Institutes of Health Stroke Scale (NIHSS) score and age were independent predictors of favorable outcomes. Conclusion: In our study, IVTT reduced the disability at the third month and can be safely performed in carefully selected patients. In older patients or those with high NIHSS scores, alternative therapies may also be considered.

13 September 2021 in SDÜ Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
HAHamit Hakan Armagan
Hamit Hakan Armagan
KKKıvanç Karaman
Kıvanç Karaman
DYDerya Yalçin Yilmaz
Derya Yalçin Yilmaz
VYVedat Ali Yürekli̇
Vedat Ali Yürekli̇
ÖÖÖzgür Önal
Özgür Önal
ÖTÖnder Tomruk
Önder Tomruk
Objective: We aimed to investigate the diagnostic accuracy of copeptin to detect transient ischemic attack (TIA) by comparing the plasma copeptin levels of patients diagnosed with TIA who were admitted to the Emergency Department (ED) with those of healthy controls. Methods: We conducted a prospective case-control study among patients admitted to the ED with a neurological symptom. The patients diagnosed with TIA by the neurologist were included. The results of electrocardiography, magnetic resonance imaging, and carotid doppler ultrasonography investigations of 38 patients; the ED outcomes (hospitalization, discharge), the risk group distribution (according to ABCD2 scores), and the variables regarding one-year re-event incidence were compared. Additionally, the serum copeptin levels of the patients were compared to those of healthy controls. Results: The mean copeptin level was 435.80 ± 316.45 pg/ml in the patient group, whereas it was 770.20 ± 912.53 pg/ml in the control group. The mean copeptin level of patients with TIA was significantly lower (p = 0.018). In the diagnosis of TIA, copeptin had 60.53% sensitivity and 68.42% specificity at a cut-off value of 386.28 pg/ml, in all the participants. In addition, in participants above 60 years old, copeptin had 75.86% sensitivity and 72.41% specificity at a cut-off value of 460.37 pg/ml. Conclusion: To the best of our knowledge, this is the first study demonstrating the high efficacy of a serum biomarker in the diagnosis of TIA. Emergency physicians should search for alternative diagnoses in patients with a low degree of clinical suspicion and a lower copeptin value. Amaç: Acil Servise (AS) başvuran TİA (Geçici iskemik atak) tanısı almış hastaların plazma kopeptin düzeylerini sağlıklı kontrollerle karşılaştırarak TİA saptamak için kopeptinin tanısal doğruluğunu araştırmayı amaçladık. Yöntemler: Acil servise nörolojik bir semptomla başvuran hastalar arasında ileriye dönük bir vaka kontrol çalışması yaptık. Nörolog tarafından TİA tanısı konan hastalar dahil edildi. 38 hastanın elektrokardiyografi, manyetik rezonans görüntüleme ve karotis doppler ultrasonografi tetkik sonuçları; Acil servis sonuçları (hastaneye yatış, taburculuk), risk grubu dağılımı (ABCD2 puanlarına göre) ve bir yıllık tekrar olay insidansına ilişkin değişkenler karşılaştırıldı. Ayrıca hastaların serum kopeptin düzeyleri sağlıklı kontrollerle karşılaştırıldı. Bulgular: Ortalama kopeptin düzeyi hasta grubunda 435.80 ± 316.45 pg/ml iken kontrol grubunda 770.20 ± 912.53 pg/ml idi. TİA'lı hastaların ortalama kopeptin düzeyi anlamlı olarak daha düşüktü (p = 0.018). TİA tanısında tüm katılımcılarda kopeptin 386.28 pg/ml cut-off değerinde %60.53 duyarlılık ve %68.42 özgüllüğe sahipti. Ayrıca 60 yaş üstü katılımcılarda kopeptin 460.37 pg/ml cut-off değerinde %75.86 duyarlılık ve %72.41 özgüllüğe sahipti. Sonuç: Bildiğimiz kadarıyla bu, bir serum biyobelirteçlerinin TİA tanısında yüksek etkinliğini gösteren ilk çalışmadır. Klinik şüphesi düşük ve kopeptin değeri düşük olan hastalarda acil hekimleri alternatif tanıları araştırmalıdır.